Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at BTIG Research from $36.00 to $29.00. They now have a "buy" rating on the stock.
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $15.00. They now have an "overweight" rating on the stock.
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $34.00 to $28.00. They now have an "outperform" rating on the stock.